Search

everythinglearnresearchcommunity

for

Search:↓

Sheehan syndrome can cause hormone deficiencies after childbirth, but treatment can improve symptoms.

A woman with Sheehan syndrome improved with hormone treatment.

Hair growth dysfunction involves various conditions with limited treatment options.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Oral contraceptives may cause hair loss in women.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Hair cortisol can indicate animal stress but varies with many factors.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

The document lists various dermatology topics, treatments, and diagnostic methods.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.